eCite Digital Repository

Monoamine transporters: vulnerable and vital doorkeepers

Citation

Lin, Z and Canales, JJ and Bjorgvinsson, T and Thomsen, M and Qu, H and Liu, Q-R and Torres, GE and Caine, SB, Monoamine transporters: vulnerable and vital doorkeepers, Progress in molecular biology and translational science, 98 pp. 1-46. ISSN 1877-1173 (2011) [Refereed Article]


Preview
PDF
552Kb
  

Copyright Statement

Copyright 2011 Elsevier

DOI: doi:10.1016/B978-0-12-385506-0.00001-6

Abstract

Transporters of dopamine, serotonin, and norepinephrine have been empirically used as medication targets for several mental illnesses in the last decades. These protein-targeted medications are effective only for subpopulations of patients with transporter-related brain disorders. Since the cDNA clonings in early 1990s, molecular studies of these transporters have revealed a wealth of information about the transporters' structure-activity relationship (SAR), neuropharmacology, cell biology, biochemistry, pharmacogenetics, and the diseases related to the human genes encoding these transporters among related regulators. Such new information creates a unique opportunity to develop transporter-specific medications based on SAR, mRNA, DNA, and perhaps transporter trafficking regulation for a number of highly relevant diseases including substance abuse, depression, schizophrenia, and Parkinson's disease.

Item Details

Item Type:Refereed Article
Research Division:Psychology and Cognitive Sciences
Research Group:Psychology
Research Field:Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)
Objective Division:Health
Objective Group:Public Health (excl. Specific Population Health)
Objective Field:Mental Health
Author:Canales, JJ (Professor Juan Canales)
ID Code:121306
Year Published:2011
Web of Science® Times Cited:19
Deposited By:Psychology
Deposited On:2017-09-21
Last Modified:2017-10-12
Downloads:11 View Download Statistics

Repository Staff Only: item control page